Hans Theodor Eich

11.2k total citations · 1 hit paper
256 papers, 4.8k citations indexed

About

Hans Theodor Eich is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hans Theodor Eich has authored 256 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 115 papers in Pathology and Forensic Medicine and 58 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hans Theodor Eich's work include Lymphoma Diagnosis and Treatment (105 papers), Lung Cancer Treatments and Mutations (63 papers) and Advanced Radiotherapy Techniques (51 papers). Hans Theodor Eich is often cited by papers focused on Lymphoma Diagnosis and Treatment (105 papers), Lung Cancer Treatments and Mutations (63 papers) and Advanced Radiotherapy Techniques (51 papers). Hans Theodor Eich collaborates with scholars based in Germany, Austria and Switzerland. Hans Theodor Eich's co-authors include Andreas Engert, Rolf‐Peter Müller, Volker Diehl, Uwe Haverkamp, Khaled Elsayad, Burkhard Greve, Martin Götte, Oliver Micke, Peter Borchmann and Michael Oertel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hans Theodor Eich

228 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

2013 358 citations Hans Theodor Eich et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Hans Theodor Eich

Since Specialization

Citations

This map shows the geographic impact of Hans Theodor Eich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Theodor Eich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Theodor Eich more than expected).

Fields of papers citing papers by Hans Theodor Eich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Theodor Eich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Theodor Eich. The network helps show where Hans Theodor Eich may publish in the future.

Co-authorship network of co-authors of Hans Theodor Eich

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Theodor Eich. A scholar is included among the top collaborators of Hans Theodor Eich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Theodor Eich. Hans Theodor Eich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low‐dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S‐MISR Study 2025 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Khaled Elsayad, Christian Kandler, (unknown), (unknown), (unknown), Gábor Dobos, Elisabeth Livingstone, Susanne Melchers, Johannes Kleemann, Julia Hyun, Claudia Pföhler, (unknown), Jan P. Nicolay, Rudolf Stadler, Hans Theodor Eich	0
2	Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Johannes Rosenbrock, (unknown), Michael Oertel, Eren Celik, (unknown), Jiaqi Fan, Dennis A. Eichenauer, Paul J. Bröckelmann, Bastian von Tresckow, Carsten Kobe, Markus Dietlein, Michael Fuchs, Peter Borchmann, Hans Theodor Eich, Christian Baues	1
3	Pegylated Interferon Combined With Low-Dose Total Skin Electron Beam Therapy for Advanced Stage Mycosis Fungoides: Two Case Reports and Literature Review 2024 ·Advances in Radiation Oncology ·Khaled Elsayad, Rudolf Stadler, Hans Theodor Eich	0
4	Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma—A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group 2024 ·Cancers ·Michael Oertel, (unknown), (unknown), (unknown), Michael Fuchs, Uwe Haverkamp, Peter Borchmann, Hans Theodor Eich	1
5	Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation 2024 ·Cancers ·Andrea Baehr, (unknown), (unknown), (unknown), (unknown), (unknown), Hans Theodor Eich, Michael Oertel	0
6	Metabolic Tumor Volume after Two Cycles of Chemotherapy in Patients Treated for Advanced-Stage Hodgkin Lymphoma: Analysis of the German Hodgkin Study Group Phase III HD18 and HD21 Trials 2024 ·Blood ·Justin Ferdinandus, (unknown), (unknown), Michael Fuchs, Hans Theodor Eich, Christian Baues, Johannes Rosenbrock, (unknown), Alexander Drzezga, (unknown), Markus Dietlein, Peter Borchmann, Carsten Kobe	1
7	Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany—results from a national survey 2024 ·Strahlentherapie und Onkologie ·(unknown), Michael Oertel, (unknown), Matthias Mäurer, Khaled Elsayad, (unknown), (unknown), Jenna Kahn, John P. Plastaras, Jillian R. Gunther, Hans Theodor Eich	0
8	Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer 2023 ·Archives of Medical Research ·(unknown), (unknown), (unknown), Nancy Adriana Espinoza‐Sánchez, (unknown), Björn Kemper, Hans Theodor Eich, Martin Götte, Burkhard Greve, Fabian M. Troschel	6
9	Molecular predictors for decitabine efficacy in meningiomas – a pilot study 2023 ·Journal of Neuro-Oncology ·Dorothee Cäcilia Spille, Christian Thomas, Andrea Wagner, Oliver Grauer, (unknown), Eva C. Bunk, Walter Stummer, Hans Theodor Eich, Werner Paulus, Volker Senner, Benjamin Brokinkel	0
10	The evolving role of reduced-dose total skin electron beam therapy in skin malignancies: the renaissance of a rare indication 2023 ·Strahlentherapie und Onkologie ·Khaled Elsayad, Hans Theodor Eich	2
11	Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Oertel, Marita Ziepert, (unknown), (unknown), Maike Nickelsen, B. Glaß, Viola Poeschel, Christian Rübe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich	1
12	Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical Study 2023 ·Cancers ·(unknown), (unknown), (unknown), Christoph Pöttgen, (unknown), (unknown), (unknown), Christos Moustakis, (unknown), Michael Oertel, Uwe Haverkamp, Martin Stuschke, Beate Timmermann, Hans Theodor Eich, Gabriele Reinartz	1
13	Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Christian Baues, Helen Goergen, Michael Fuchs, Johannes Rosenbrock, Eren Celik, Hans Theodor Eich, Carsten Kobe, Conrad‐Amadeus Voltin, Andreas Engert, Peter Borchmann, Simone Marnitz	6
14	Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review 2020 ·Strahlentherapie und Onkologie ·Sergiu Scobioala, Hans Theodor Eich	7
15	Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck 2018 ·Oncology Research and Treatment ·(unknown), Khaled Elsayad, Markus Stenner, Claudia Rudack, Uwe Haverkamp, (unknown), Eva Wardelmann, Hans Theodor Eich	12
16	Radiotherapy Is Effective for Desmoid Tumors (Aggressive Fibromatosis) - Long-Term Results of a German Multicenter Study 2014 ·Oncology Research and Treatment ·Jan Kříž, Hans Theodor Eich, Uwe Haverkamp, M. H. Seegenschmiedt, (unknown), Frank Bruns, Oliver Micke	27
17	The German evidence-based guidelines for Hodgkin’s lymphoma 2013 ·Strahlentherapie und Onkologie ·Hans Theodor Eich, (unknown), Heinz Schmidberger, Boris Böll, Beate Klimm, Michaela Rancea, R.-P. Müller, Andreas Engert	3
18	Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma 2012 ·Annals of Oncology ·Stephanie Sasse, Beate Klimm, Helen Görgen, Michael Fuchs, (unknown), Andreas Lohri, Olaf Koch, Mathias Wilhelm, Guido Trenn, Jürgen Finke, R.-P. Müller, Volker Diehl, Hans Theodor Eich, Peter Borchmann, Andreas Engert	25
19	Involved-Node Radiotherapy in Early-Stage Hodgkin’s Lymphoma 2008 ·Strahlentherapie und Onkologie ·Hans Theodor Eich, Rolf‐Peter Müller, (unknown), Rita Engenhart‐Cabillic, Peter Lukáš, Heinz Schmidberger, S. Staar, Normann Willich	61
20	Lymphocyte‐predominant and classical Hodgkin's lymphoma – comparison of outcomes 2005 ·European Journal Of Haematology ·(unknown), Thorsten Reineke, Andreas Josting, Hans Konrad Müller‐Hermelink, Hans Theodor Eich, Karolin Behringer, Rolf‐Peter Müller, Volker Diehl, Andreas Engert	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact